9-21 | A massive scale-up of humanitarian aid in Bangladesh is needed to avoid a massive public health disaster following the arrival of hundreds of thousands of Rohingya refugees, says Médecins Sans Frontières/Doctors Without Borders (MSF). Following a wave of targeted violence against Rohingyas more than 422,000 people have fled to Bangladesh from Rakhine State in Myanmar within a three week period.
9-18 | International humanitarian organizations must immediately be granted independent and unfettered access, including for international staff, to alleviate massive humanitarian needs in Rakhine State, Myanmar, says Médecins Sans Frontières/Doctors Without Borders (MSF). The call for urgent access comes amidst the ongoing military operations in Rakhine, which started on 25 August after a new spate of attacks against police stations and a military base claimed by the Arakan Rohingya Salvation Army (ARSA).
9-14 | Here is an update from MSF Emergency Operations Manager Karline Kleijer on the situation of the Rohingya in Rakhine State:
9-6 | Rohingya refugees fleeing to Bangladesh urgently require medical and humanitarian assistance, as an already dire humanitarian situation along the border with Myanmar worsens. By 6 September, over 146,000 people had crossed into Bangladesh, fleeing violence in Rakhine state, Myanmar. This figure, coming on top of 75,000 people who have arrived since violence began in October 2016, represents one of the largest influxes ever of Rohingyas into Bangladesh.
8-22 | Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that safeguards both children and adults from pneumonia was dealt a major blow after the Indian patent office granted a patent to the US pharmaceutical corporation Pfizer for its PCV13 product, marketed as Prevnar13. “It’s unfair and unacceptable that almost a million children die each year from pneumonia, even though a life-saving vaccine is available.